Billiontoone (NASDAQ:BLLN) Share Price Breaks Below 50 Day Moving Average – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report)’s share price crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $106.99 and traded as low as $104.35. Billiontoone shares last traded at $105.15, with a volume of 647,690 shares.

Analyst Upgrades and Downgrades

BLLN has been the topic of a number of recent research reports. Piper Sandler dropped their target price on Billiontoone from $140.00 to $130.00 and set an “overweight” rating on the stock in a report on Tuesday, November 10th. Guggenheim lifted their target price on Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. upped their price target on Billiontoone from $130.00 to $135.00 and gave the stock an “overweight” rating in a report on Thursday, November 5th. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, BTIG Research restated a “buy” rating and set a $130.00 price objective on shares of Billiontoone in a research note on Thursday, November 5th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $124.38.

Get Our Latest Research Report on Billiontoone

Billiontoone Trading Down 5.1%

The firm has a market capitalization of $5.02 billion and a PE ratio of 114.29. The firm’s fifty day moving average is $106.99 and its two-hundred day moving average is $97.74. The company has a debt-to-equity ratio of 0.16, a current ratio of 11.25 and a quick ratio of 10.89.

Insider Buying and Selling at Billiontoone

In other Billiontoone news, CEO Oguzhan Atay sold 25,001 shares of Billiontoone stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total transaction of $2,731,109.24. Following the transaction, the chief executive officer owned 16,667 shares of the company’s stock, valued at $1,820,703.08. This trade represents a 60.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 2,834 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $113.17, for a total value of $320,723.78. Following the completion of the transaction, the senior vice president owned 16,551 shares in the company, valued at $1,873,076.67. The trade was a 14.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 252,777 shares of company stock worth $26,737,151. Insiders own 50.22% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of BLLN. Entropy Technologies LP grew its stake in Billiontoone by 43.3% in the 3rd quarter. Entropy Technologies LP now owns 9,600 shares of the company’s stock valued at $1,022,000 after purchasing an additional 2,900 shares during the period. FORA Capital LLC purchased a new stake in shares of Billiontoone during the 3rd quarter valued at $495,000. Marshall Wace LLP increased its position in shares of Billiontoone by 620.0% during the 3rd quarter. Marshall Wace LLP now owns 321,546 shares of the company’s stock valued at $34,225,000 after purchasing an additional 276,884 shares during the last quarter. State Street Corp raised its stake in shares of Billiontoone by 101.7% during the 3rd quarter. State Street Corp now owns 144,075 shares of the company’s stock worth $15,335,000 after purchasing an additional 72,639 shares during the period. Finally, Ieq Capital LLC bought a new stake in shares of Billiontoone during the 3rd quarter worth $219,000.

About Billiontoone

(Get Free Report)

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

Recommended Stories

Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.